奥沙利铂洗脱微球治疗肝内胆管癌：病例报告
Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report.
作者信息
Poggi Guido, Quaretti Pietro, Minoia Claudio, Palumbo Ilaria, Villani Laura, Amatu Alessio, Teragni Cristina, Scelsi Mario, Zappoli Federico, Bernardo Giovanni
机构信息
Department of Oncology, Fondazione S. Maugeri, Istituto Scientifico di Pavia, Italy.
出版信息
Anticancer Res. 2008 Sep-Oct;28(5B):2987-90.
Intrahepatic cholangiocarcinoma account for 13% of annual cancer-related deaths worldwide and for 3% in the USA. Patient with unresectable disease can benefit from palliative therapies such as systemic chemotherapy. However, the only curative treatment for intrahepatic cholangiocarcinoma is complete surgical resection with histologically negative resection margins.
肝内胆管癌占全球每年癌症相关死亡人数的13%，在美国占3%。患有不可切除疾病的患者可从全身化疗等姑息治疗中获益。然而，肝内胆管癌的唯一治愈性治疗方法是进行手术切除，且切除边缘的组织学检查为阴性。
Zotero 插件